Raymond James Downgrade Sends DaVita Shares Plummeting

By: Benzinga
In a report out of Raymond James Tuesday morning, analyst John W. Ransom downgraded DaVita Healthcare (NYSE: DVA ) from an Outperform rating to a Market Perform rating, while removing his $125 price target on the company. The report focused on a ruling Monday night that the worst case calendar
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.